While the IMPDH2 mutation generally leads to downregulation of glycolytic pathway and PPP enzyme mRNA levels in most mutant HEC‐1‐A, CE81T, and HeLa cell‐derived tumours, this trend is less apparent in mutant HCT116 cell‐derived tumours. The gene discussed is IMPDH2; the disease is neoplasm.